|
XB--987153
Papers associated with slc15a1 (and slco1a2)
???pagination.result.count???
???pagination.result.page??? 1
| Sort Newest To Oldest | Sort Oldest To Newest |
Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems., Takusagawa S, Ushigome F, Nemoto H, Takahashi Y, Li Q, Kerbusch V, Miyashita A, Iwatsubo T, Usui T., Mol Pharm. May 6, 2013; 10 (5): 1783-94. |
|
Raltegravir is a substrate for SLC22A6: a putative mechanism for the interaction between raltegravir and tenofovir., Moss DM, Kwan WS, Liptrott NJ, Smith DL, Siccardi M, Khoo SH, Back DJ, Owen A., Antimicrob Agents Chemother. February 1, 2011; 55 (2): 879-87. |
|
Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport., Kato K, Shirasaka Y, Kuraoka E, Kikuchi A, Iguchi M, Suzuki H, Shibasaki S, Kurosawa T, Tamai I., Mol Pharm. October 4, 2010; 7 (5): 1747-56. |
|
The peptide-based thrombin inhibitor CRC 220 is a new substrate of the basolateral rat liver organic anion-transporting polypeptide., Eckhardt U, Horz JA, Petzinger E, Stüber W, Reers M, Dickneite G, Daniel H, Wagener M, Hagenbuch B, Stieger B, Meier PJ., Hepatology. August 1, 1996; 24 (2): 380-4. |
???pagination.result.page??? 1